ArticleJournal of molecular medicine (Berlin, Germany)2016

Isoliquiritigenin prevents the progression of psoriasis-like symptoms by inhibiting NF-κB and proinflammatory cytokines.

Yangping Wu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.